Physician profile
Joseph Anthony Osorio
NPI 1437416591
$1,341,133.72
in general payments reported to CMS, 2019-2025
24 companies · $243K in 2025
The $243K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,676 · 2020: $93K · 2021: $205K · 2022: $311K · 2023: $165K · 2024: $321K · 2025: $243K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $269K · Consulting Fee: $250K · Royalty Or License: $117K · Travel and Lodging: $79K · Food and Beverage: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $268,540.00 |
| Consulting Fee | $250,307.14 |
| Royalty Or License | $117,181.48 |
| Travel and Lodging | $78,995.04 |
| Food and Beverage | $14,384.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $866,064.35 | 2021-2025 | Unid_pass, Mazor X System, Cd Horizon Spinal System |
| Alphatec Spine, INC | $227,182.76 | 2019-2025 | Other - Miscellaneous, Invictus Open, Battalion Tlif - Pc |
| Carlsmed, INC. | $128,031.47 | 2021-2025 | Aprevo |
| Medtronic USA, INC. | $52,309.39 | 2019-2020 | |
| Medical Device Business Services, INC. | $44,654.11 | 2020-2023 | Symphony |
| Carbofix Spine INC | $7,175.00 | 2020 | |
| Depuy Synthes Products, INC. | $6,775.69 | 2020 | |
| Kuros Biosciences USA, INC | $6,230.28 | 2021-2022 | |
| Depuy Synthes Sales INC. | $450.33 | 2019-2021 | |
| Stryker Corporation | $384.65 | 2019-2022 | |
| Nuvasive, INC. | $287.20 | 2019-2022 | |
| Acuity Surgical Devices, LLC | $223.13 | 2019 | |
| Centinel Spine, LLC | $213.09 | 2025 | Prodisc L |
| Zimmer Biomet Holdings, INC. | $198.75 | 2022 | |
| Boston Scientific Corporation | $190.11 | 2020-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $150.00 | 2025 | Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Axis Spine Technologies INC. | $119.37 | 2025 | Axis Spine Technologies Alif Implant |
| Nalu Medical, INC. | $106.52 | 2021 | |
| Orthofix Medical, INC. | $100.62 | 2025 | Mariner |
| Medicrea USA, Corp. | $76.01 | 2019 | |
| Djo, LLC | $73.88 | 2021-2023 | Cmf |
| Biocomposites INC | $57.19 | 2024 | |
| Si-Bone, INC. | $45.38 | 2020 | |
| Globus Medical, INC. | $34.44 | 2025 | Excelsius Gps, Simplify Cervical Artificial Disc, Reline |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Osorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.